Key result
Triple comorbidity of hypertension, diabetes, and dyslipidemia affects ~4% of Hainan adults.
Why the study?
Hypertension, diabetes, and dyslipidemia commonly co-occur due to shared pathophysiology, but their clustering prevalence and associated factors in Hainan adults were not well characterized.
Cross-Sectional (n=32,857)
Yes
In Hainan, China, hypertension-dyslipidemia is the predominant cardiometabolic comorbidity phenotype among adults, highlighting an urgent public health need for integrated multi-disease screening and targeted interventions.
Answers are grounded in this paper and cite their sources.
Hypertension-dyslipidemia predominates among metabolic comorbidities in Hainan adults; extends regional prevalence data but leaves open generalizability and intervention effects.
What is already known about this topic?Hypertension, diabetes, and dyslipidemia are metabolically interconnected.Although each may arise independently, shared pathophysiology commonly drives synergistic co-occurrence. What is added by this report?In Hainan, China's tropical island province, the weighted prevalence of hypertension-dyslipidemia comorbidity exceeded that of diabetes-dyslipidemia and hypertension-diabetes, as well as their triple comorbidity.Hypertensive-dyslipidemic clustering represented the predominant comorbidity phenotype, with implications for targeted screening and integrated prevention. What are the implications for public health practice?This study provides a descriptive baseline assessment highlighting high-risk subpopulations, establishing a critical evidence base for planning/design of intervention strategies.
No takes yet. Share an insight, caveat, or question.
Juan et al. (2026) conducted a cross-sectional in Hypertension, diabetes, and dyslipidemia (cardiometabolic comorbidity) (n=32,857). Population-wide cardiometabolic screening was evaluated on Weighted prevalence of triple comorbidity (hypertension, diabetes, and dyslipidemia). Among adults in Hainan, China, the weighted prevalence of hypertension, diabetes, and dyslipidemia triple comorbidity was 4.07%, while hypertension-dyslipidemia was the most prevalent pairwise comorbidity at 10.55%.
Synapse has enriched 10 related papers. Consider them for comparative context: